Global Insulin Sensitizers Market Growth 2022-2028
The global market for Insulin Sensitizers is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Insulin Sensitizers market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Insulin Sensitizers market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Insulin Sensitizers market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Insulin Sensitizers market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Insulin Sensitizers players cover Sanofi, Novo Nordisk, Lilly, MSD and Boehringer Ingelheim, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Insulin Sensitizers market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Insulin Sensitizers market, with both quantitative and qualitative data, to help readers understand how the Insulin Sensitizers market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Insulin Sensitizers market and forecasts the market size by Type (Thiazolidinediones, Biguanides and Others), by Sales Channels (Hospital and Drugstore.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Thiazolidinediones
Biguanides
Others
Segmentation by sales channels
Hospital
Drugstore
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Sanofi
Novo Nordisk
Lilly
MSD
Boehringer Ingelheim
Chipscreen Biosciences
Shandong Lukang Pharmaceutical
Zhejiang Hisun Pharmaceutical
SPH Zhongxi Pharmaceutical
Guizhou Shengjitang Pharmaceutical
Chengdu Hengrui Pharmaceutical
Zhejiang Wansheng Pharmaceutical
Shenzhen Neptunus Pharmaceutical
Shanghai Kaibao Pharmaceutical
Hangzhou Conba Pharmaceutical
Chapter Introduction
Chapter 1: Scope of Insulin Sensitizers, Research Methodology, etc.
Chapter 2: Executive Summary, global Insulin Sensitizers market size (sales and revenue) and CAGR, Insulin Sensitizers market size by region, by type, by sales channels, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Insulin Sensitizers sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Insulin Sensitizers sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Insulin Sensitizers market size forecast by region, by country, by type, and sales channels.
Chapter 13: Comprehensive company profiles of the leading players, including Sanofi, Novo Nordisk, Lilly, MSD, Boehringer Ingelheim, Chipscreen Biosciences, Shandong Lukang Pharmaceutical, Zhejiang Hisun Pharmaceutical and SPH Zhongxi Pharmaceutical, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Insulin Sensitizers Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Insulin Sensitizers by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Insulin Sensitizers by Country/Region, 2017, 2022 & 2028
2.2 Insulin Sensitizers Segment by Type
2.2.1 Thiazolidinediones
2.2.2 Biguanides
2.2.3 Others
2.3 Insulin Sensitizers Sales by Type
2.3.1 Global Insulin Sensitizers Sales Market Share by Type (2017-2022)
2.3.2 Global Insulin Sensitizers Revenue and Market Share by Type (2017-2022)
2.3.3 Global Insulin Sensitizers Sale Price by Type (2017-2022)
2.4 Insulin Sensitizers Segment by Sales Channels
2.4.1 Hospital
2.4.2 Drugstore
2.5 Insulin Sensitizers Sales by Sales Channels
2.5.1 Global Insulin Sensitizers Sale Market Share by Sales Channels (2017-2022)
2.5.2 Global Insulin Sensitizers Revenue and Market Share by Sales Channels (2017-2022)
2.5.3 Global Insulin Sensitizers Sale Price by Sales Channels (2017-2022)
3 Global Insulin Sensitizers by Company
3.1 Global Insulin Sensitizers Breakdown Data by Company
3.1.1 Global Insulin Sensitizers Annual Sales by Company (2020-2022)
3.1.2 Global Insulin Sensitizers Sales Market Share by Company (2020-2022)
3.2 Global Insulin Sensitizers Annual Revenue by Company (2020-2022)
3.2.1 Global Insulin Sensitizers Revenue by Company (2020-2022)
3.2.2 Global Insulin Sensitizers Revenue Market Share by Company (2020-2022)
3.3 Global Insulin Sensitizers Sale Price by Company
3.4 Key Manufacturers Insulin Sensitizers Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Insulin Sensitizers Product Location Distribution
3.4.2 Players Insulin Sensitizers Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Insulin Sensitizers by Geographic Region
4.1 World Historic Insulin Sensitizers Market Size by Geographic Region (2017-2022)
4.1.1 Global Insulin Sensitizers Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Insulin Sensitizers Annual Revenue by Geographic Region
4.2 World Historic Insulin Sensitizers Market Size by Country/Region (2017-2022)
4.2.1 Global Insulin Sensitizers Annual Sales by Country/Region (2017-2022)
4.2.2 Global Insulin Sensitizers Annual Revenue by Country/Region
4.3 Americas Insulin Sensitizers Sales Growth
4.4 APAC Insulin Sensitizers Sales Growth
4.5 Europe Insulin Sensitizers Sales Growth
4.6 Middle East & Africa Insulin Sensitizers Sales Growth
5 Americas
5.1 Americas Insulin Sensitizers Sales by Country
5.1.1 Americas Insulin Sensitizers Sales by Country (2017-2022)
5.1.2 Americas Insulin Sensitizers Revenue by Country (2017-2022)
5.2 Americas Insulin Sensitizers Sales by Type
5.3 Americas Insulin Sensitizers Sales by Sales Channels
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Insulin Sensitizers Sales by Region
6.1.1 APAC Insulin Sensitizers Sales by Region (2017-2022)
6.1.2 APAC Insulin Sensitizers Revenue by Region (2017-2022)
6.2 APAC Insulin Sensitizers Sales by Type
6.3 APAC Insulin Sensitizers Sales by Sales Channels
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Insulin Sensitizers by Country
7.1.1 Europe Insulin Sensitizers Sales by Country (2017-2022)
7.1.2 Europe Insulin Sensitizers Revenue by Country (2017-2022)
7.2 Europe Insulin Sensitizers Sales by Type
7.3 Europe Insulin Sensitizers Sales by Sales Channels
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Insulin Sensitizers by Country
8.1.1 Middle East & Africa Insulin Sensitizers Sales by Country (2017-2022)
8.1.2 Middle East & Africa Insulin Sensitizers Revenue by Country (2017-2022)
8.2 Middle East & Africa Insulin Sensitizers Sales by Type
8.3 Middle East & Africa Insulin Sensitizers Sales by Sales Channels
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Insulin Sensitizers
10.3 Manufacturing Process Analysis of Insulin Sensitizers
10.4 Industry Chain Structure of Insulin Sensitizers
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Insulin Sensitizers Distributors
11.3 Insulin Sensitizers Customer
12 World Forecast Review for Insulin Sensitizers by Geographic Region
12.1 Global Insulin Sensitizers Market Size Forecast by Region
12.1.1 Global Insulin Sensitizers Forecast by Region (2023-2028)
12.1.2 Global Insulin Sensitizers Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Insulin Sensitizers Forecast by Type
12.7 Global Insulin Sensitizers Forecast by Sales Channels
13 Key Players Analysis
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Insulin Sensitizers Product Offered
13.1.3 Sanofi Insulin Sensitizers Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Novo Nordisk
13.2.1 Novo Nordisk Company Information
13.2.2 Novo Nordisk Insulin Sensitizers Product Offered
13.2.3 Novo Nordisk Insulin Sensitizers Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Novo Nordisk Main Business Overview
13.2.5 Novo Nordisk Latest Developments
13.3 Lilly
13.3.1 Lilly Company Information
13.3.2 Lilly Insulin Sensitizers Product Offered
13.3.3 Lilly Insulin Sensitizers Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Lilly Main Business Overview
13.3.5 Lilly Latest Developments
13.4 MSD
13.4.1 MSD Company Information
13.4.2 MSD Insulin Sensitizers Product Offered
13.4.3 MSD Insulin Sensitizers Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 MSD Main Business Overview
13.4.5 MSD Latest Developments
13.5 Boehringer Ingelheim
13.5.1 Boehringer Ingelheim Company Information
13.5.2 Boehringer Ingelheim Insulin Sensitizers Product Offered
13.5.3 Boehringer Ingelheim Insulin Sensitizers Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Boehringer Ingelheim Main Business Overview
13.5.5 Boehringer Ingelheim Latest Developments
13.6 Chipscreen Biosciences
13.6.1 Chipscreen Biosciences Company Information
13.6.2 Chipscreen Biosciences Insulin Sensitizers Product Offered
13.6.3 Chipscreen Biosciences Insulin Sensitizers Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Chipscreen Biosciences Main Business Overview
13.6.5 Chipscreen Biosciences Latest Developments
13.7 Shandong Lukang Pharmaceutical
13.7.1 Shandong Lukang Pharmaceutical Company Information
13.7.2 Shandong Lukang Pharmaceutical Insulin Sensitizers Product Offered
13.7.3 Shandong Lukang Pharmaceutical Insulin Sensitizers Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Shandong Lukang Pharmaceutical Main Business Overview
13.7.5 Shandong Lukang Pharmaceutical Latest Developments
13.8 Zhejiang Hisun Pharmaceutical
13.8.1 Zhejiang Hisun Pharmaceutical Company Information
13.8.2 Zhejiang Hisun Pharmaceutical Insulin Sensitizers Product Offered
13.8.3 Zhejiang Hisun Pharmaceutical Insulin Sensitizers Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Zhejiang Hisun Pharmaceutical Main Business Overview
13.8.5 Zhejiang Hisun Pharmaceutical Latest Developments
13.9 SPH Zhongxi Pharmaceutical
13.9.1 SPH Zhongxi Pharmaceutical Company Information
13.9.2 SPH Zhongxi Pharmaceutical Insulin Sensitizers Product Offered
13.9.3 SPH Zhongxi Pharmaceutical Insulin Sensitizers Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 SPH Zhongxi Pharmaceutical Main Business Overview
13.9.5 SPH Zhongxi Pharmaceutical Latest Developments
13.10 Guizhou Shengjitang Pharmaceutical
13.10.1 Guizhou Shengjitang Pharmaceutical Company Information
13.10.2 Guizhou Shengjitang Pharmaceutical Insulin Sensitizers Product Offered
13.10.3 Guizhou Shengjitang Pharmaceutical Insulin Sensitizers Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Guizhou Shengjitang Pharmaceutical Main Business Overview
13.10.5 Guizhou Shengjitang Pharmaceutical Latest Developments
13.11 Chengdu Hengrui Pharmaceutical
13.11.1 Chengdu Hengrui Pharmaceutical Company Information
13.11.2 Chengdu Hengrui Pharmaceutical Insulin Sensitizers Product Offered
13.11.3 Chengdu Hengrui Pharmaceutical Insulin Sensitizers Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Chengdu Hengrui Pharmaceutical Main Business Overview
13.11.5 Chengdu Hengrui Pharmaceutical Latest Developments
13.12 Zhejiang Wansheng Pharmaceutical
13.12.1 Zhejiang Wansheng Pharmaceutical Company Information
13.12.2 Zhejiang Wansheng Pharmaceutical Insulin Sensitizers Product Offered
13.12.3 Zhejiang Wansheng Pharmaceutical Insulin Sensitizers Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Zhejiang Wansheng Pharmaceutical Main Business Overview
13.12.5 Zhejiang Wansheng Pharmaceutical Latest Developments
13.13 Shenzhen Neptunus Pharmaceutical
13.13.1 Shenzhen Neptunus Pharmaceutical Company Information
13.13.2 Shenzhen Neptunus Pharmaceutical Insulin Sensitizers Product Offered
13.13.3 Shenzhen Neptunus Pharmaceutical Insulin Sensitizers Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Shenzhen Neptunus Pharmaceutical Main Business Overview
13.13.5 Shenzhen Neptunus Pharmaceutical Latest Developments
13.14 Shanghai Kaibao Pharmaceutical
13.14.1 Shanghai Kaibao Pharmaceutical Company Information
13.14.2 Shanghai Kaibao Pharmaceutical Insulin Sensitizers Product Offered
13.14.3 Shanghai Kaibao Pharmaceutical Insulin Sensitizers Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Shanghai Kaibao Pharmaceutical Main Business Overview
13.14.5 Shanghai Kaibao Pharmaceutical Latest Developments
13.15 Hangzhou Conba Pharmaceutical
13.15.1 Hangzhou Conba Pharmaceutical Company Information
13.15.2 Hangzhou Conba Pharmaceutical Insulin Sensitizers Product Offered
13.15.3 Hangzhou Conba Pharmaceutical Insulin Sensitizers Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Hangzhou Conba Pharmaceutical Main Business Overview
13.15.5 Hangzhou Conba Pharmaceutical Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Insulin Sensitizers Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Insulin Sensitizers Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Thiazolidinediones
Table 4. Major Players of Biguanides
Table 5. Major Players of Others
Table 6. Global Insulin Sensitizers Sales by Type (2017-2022) & (K Units)
Table 7. Global Insulin Sensitizers Sales Market Share by Type (2017-2022)
Table 8. Global Insulin Sensitizers Revenue by Type (2017-2022) & ($ million)
Table 9. Global Insulin Sensitizers Revenue Market Share by Type (2017-2022)
Table 10. Global Insulin Sensitizers Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Insulin Sensitizers Sales by Sales Channels (2017-2022) & (K Units)
Table 12. Global Insulin Sensitizers Sales Market Share by Sales Channels (2017-2022)
Table 13. Global Insulin Sensitizers Revenue by Sales Channels (2017-2022)
Table 14. Global Insulin Sensitizers Revenue Market Share by Sales Channels (2017-2022)
Table 15. Global Insulin Sensitizers Sale Price by Sales Channels (2017-2022) & (US$/Unit)
Table 16. Global Insulin Sensitizers Sales by Company (2020-2022) & (K Units)
Table 17. Global Insulin Sensitizers Sales Market Share by Company (2020-2022)
Table 18. Global Insulin Sensitizers Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Insulin Sensitizers Revenue Market Share by Company (2020-2022)
Table 20. Global Insulin Sensitizers Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Insulin Sensitizers Producing Area Distribution and Sales Area
Table 22. Players Insulin Sensitizers Products Offered
Table 23. Insulin Sensitizers Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Insulin Sensitizers Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Insulin Sensitizers Sales Market Share Geographic Region (2017-2022)
Table 28. Global Insulin Sensitizers Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Insulin Sensitizers Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Insulin Sensitizers Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Insulin Sensitizers Sales Market Share by Country/Region (2017-2022)
Table 32. Global Insulin Sensitizers Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Insulin Sensitizers Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Insulin Sensitizers Sales by Country (2017-2022) & (K Units)
Table 35. Americas Insulin Sensitizers Sales Market Share by Country (2017-2022)
Table 36. Americas Insulin Sensitizers Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Insulin Sensitizers Revenue Market Share by Country (2017-2022)
Table 38. Americas Insulin Sensitizers Sales by Type (2017-2022) & (K Units)
Table 39. Americas Insulin Sensitizers Sales Market Share by Type (2017-2022)
Table 40. Americas Insulin Sensitizers Sales by Sales Channels (2017-2022) & (K Units)
Table 41. Americas Insulin Sensitizers Sales Market Share by Sales Channels (2017-2022)
Table 42. APAC Insulin Sensitizers Sales by Region (2017-2022) & (K Units)
Table 43. APAC Insulin Sensitizers Sales Market Share by Region (2017-2022)
Table 44. APAC Insulin Sensitizers Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Insulin Sensitizers Revenue Market Share by Region (2017-2022)
Table 46. APAC Insulin Sensitizers Sales by Type (2017-2022) & (K Units)
Table 47. APAC Insulin Sensitizers Sales Market Share by Type (2017-2022)
Table 48. APAC Insulin Sensitizers Sales by Sales Channels (2017-2022) & (K Units)
Table 49. APAC Insulin Sensitizers Sales Market Share by Sales Channels (2017-2022)
Table 50. Europe Insulin Sensitizers Sales by Country (2017-2022) & (K Units)
Table 51. Europe Insulin Sensitizers Sales Market Share by Country (2017-2022)
Table 52. Europe Insulin Sensitizers Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Insulin Sensitizers Revenue Market Share by Country (2017-2022)
Table 54. Europe Insulin Sensitizers Sales by Type (2017-2022) & (K Units)
Table 55. Europe Insulin Sensitizers Sales Market Share by Type (2017-2022)
Table 56. Europe Insulin Sensitizers Sales by Sales Channels (2017-2022) & (K Units)
Table 57. Europe Insulin Sensitizers Sales Market Share by Sales Channels (2017-2022)
Table 58. Middle East & Africa Insulin Sensitizers Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Insulin Sensitizers Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Insulin Sensitizers Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Insulin Sensitizers Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Insulin Sensitizers Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Insulin Sensitizers Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Insulin Sensitizers Sales by Sales Channels (2017-2022) & (K Units)
Table 65. Middle East & Africa Insulin Sensitizers Sales Market Share by Sales Channels (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Insulin Sensitizers
Table 67. Key Market Challenges & Risks of Insulin Sensitizers
Table 68. Key Industry Trends of Insulin Sensitizers
Table 69. Insulin Sensitizers Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Insulin Sensitizers Distributors List
Table 72. Insulin Sensitizers Customer List
Table 73. Global Insulin Sensitizers Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Insulin Sensitizers Sales Market Forecast by Region
Table 75. Global Insulin Sensitizers Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Insulin Sensitizers Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Insulin Sensitizers Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Insulin Sensitizers Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Insulin Sensitizers Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Insulin Sensitizers Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Insulin Sensitizers Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Insulin Sensitizers Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Insulin Sensitizers Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Insulin Sensitizers Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Insulin Sensitizers Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Insulin Sensitizers Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Insulin Sensitizers Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Insulin Sensitizers Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Insulin Sensitizers Sales Forecast by Sales Channels (2023-2028) & (K Units)
Table 90. Global Insulin Sensitizers Sales Market Share Forecast by Sales Channels (2023-2028)
Table 91. Global Insulin Sensitizers Revenue Forecast by Sales Channels (2023-2028) & ($ Millions)
Table 92. Global Insulin Sensitizers Revenue Market Share Forecast by Sales Channels (2023-2028)
Table 93. Sanofi Basic Information, Insulin Sensitizers Manufacturing Base, Sales Area and Its Competitors
Table 94. Sanofi Insulin Sensitizers Product Offered
Table 95. Sanofi Insulin Sensitizers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Sanofi Main Business
Table 97. Sanofi Latest Developments
Table 98. Novo Nordisk Basic Information, Insulin Sensitizers Manufacturing Base, Sales Area and Its Competitors
Table 99. Novo Nordisk Insulin Sensitizers Product Offered
Table 100. Novo Nordisk Insulin Sensitizers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Novo Nordisk Main Business
Table 102. Novo Nordisk Latest Developments
Table 103. Lilly Basic Information, Insulin Sensitizers Manufacturing Base, Sales Area and Its Competitors
Table 104. Lilly Insulin Sensitizers Product Offered
Table 105. Lilly Insulin Sensitizers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Lilly Main Business
Table 107. Lilly Latest Developments
Table 108. MSD Basic Information, Insulin Sensitizers Manufacturing Base, Sales Area and Its Competitors
Table 109. MSD Insulin Sensitizers Product Offered
Table 110. MSD Insulin Sensitizers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. MSD Main Business
Table 112. MSD Latest Developments
Table 113. Boehringer Ingelheim Basic Information, Insulin Sensitizers Manufacturing Base, Sales Area and Its Competitors
Table 114. Boehringer Ingelheim Insulin Sensitizers Product Offered
Table 115. Boehringer Ingelheim Insulin Sensitizers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Boehringer Ingelheim Main Business
Table 117. Boehringer Ingelheim Latest Developments
Table 118. Chipscreen Biosciences Basic Information, Insulin Sensitizers Manufacturing Base, Sales Area and Its Competitors
Table 119. Chipscreen Biosciences Insulin Sensitizers Product Offered
Table 120. Chipscreen Biosciences Insulin Sensitizers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Chipscreen Biosciences Main Business
Table 122. Chipscreen Biosciences Latest Developments
Table 123. Shandong Lukang Pharmaceutical Basic Information, Insulin Sensitizers Manufacturing Base, Sales Area and Its Competitors
Table 124. Shandong Lukang Pharmaceutical Insulin Sensitizers Product Offered
Table 125. Shandong Lukang Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Shandong Lukang Pharmaceutical Main Business
Table 127. Shandong Lukang Pharmaceutical Latest Developments
Table 128. Zhejiang Hisun Pharmaceutical Basic Information, Insulin Sensitizers Manufacturing Base, Sales Area and Its Competitors
Table 129. Zhejiang Hisun Pharmaceutical Insulin Sensitizers Product Offered
Table 130. Zhejiang Hisun Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Zhejiang Hisun Pharmaceutical Main Business
Table 132. Zhejiang Hisun Pharmaceutical Latest Developments
Table 133. SPH Zhongxi Pharmaceutical Basic Information, Insulin Sensitizers Manufacturing Base, Sales Area and Its Competitors
Table 134. SPH Zhongxi Pharmaceutical Insulin Sensitizers Product Offered
Table 135. SPH Zhongxi Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. SPH Zhongxi Pharmaceutical Main Business
Table 137. SPH Zhongxi Pharmaceutical Latest Developments
Table 138. Guizhou Shengjitang Pharmaceutical Basic Information, Insulin Sensitizers Manufacturing Base, Sales Area and Its Competitors
Table 139. Guizhou Shengjitang Pharmaceutical Insulin Sensitizers Product Offered
Table 140. Guizhou Shengjitang Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Guizhou Shengjitang Pharmaceutical Main Business
Table 142. Guizhou Shengjitang Pharmaceutical Latest Developments
Table 143. Chengdu Hengrui Pharmaceutical Basic Information, Insulin Sensitizers Manufacturing Base, Sales Area and Its Competitors
Table 144. Chengdu Hengrui Pharmaceutical Insulin Sensitizers Product Offered
Table 145. Chengdu Hengrui Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Chengdu Hengrui Pharmaceutical Main Business
Table 147. Chengdu Hengrui Pharmaceutical Latest Developments
Table 148. Zhejiang Wansheng Pharmaceutical Basic Information, Insulin Sensitizers Manufacturing Base, Sales Area and Its Competitors
Table 149. Zhejiang Wansheng Pharmaceutical Insulin Sensitizers Product Offered
Table 150. Zhejiang Wansheng Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Zhejiang Wansheng Pharmaceutical Main Business
Table 152. Zhejiang Wansheng Pharmaceutical Latest Developments
Table 153. Shenzhen Neptunus Pharmaceutical Basic Information, Insulin Sensitizers Manufacturing Base, Sales Area and Its Competitors
Table 154. Shenzhen Neptunus Pharmaceutical Insulin Sensitizers Product Offered
Table 155. Shenzhen Neptunus Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. Shenzhen Neptunus Pharmaceutical Main Business
Table 157. Shenzhen Neptunus Pharmaceutical Latest Developments
Table 158. Shanghai Kaibao Pharmaceutical Basic Information, Insulin Sensitizers Manufacturing Base, Sales Area and Its Competitors
Table 159. Shanghai Kaibao Pharmaceutical Insulin Sensitizers Product Offered
Table 160. Shanghai Kaibao Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. Shanghai Kaibao Pharmaceutical Main Business
Table 162. Shanghai Kaibao Pharmaceutical Latest Developments
Table 163. Hangzhou Conba Pharmaceutical Basic Information, Insulin Sensitizers Manufacturing Base, Sales Area and Its Competitors
Table 164. Hangzhou Conba Pharmaceutical Insulin Sensitizers Product Offered
Table 165. Hangzhou Conba Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 166. Hangzhou Conba Pharmaceutical Main Business
Table 167. Hangzhou Conba Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Insulin Sensitizers
Figure 2. Insulin Sensitizers Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Insulin Sensitizers Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Insulin Sensitizers Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Insulin Sensitizers Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Thiazolidinediones
Figure 10. Product Picture of Biguanides
Figure 11. Product Picture of Others
Figure 12. Global Insulin Sensitizers Sales Market Share by Type in 2021
Figure 13. Global Insulin Sensitizers Revenue Market Share by Type (2017-2022)
Figure 14. Insulin Sensitizers Consumed in Hospital
Figure 15. Global Insulin Sensitizers Market: Hospital (2017-2022) & (K Units)
Figure 16. Insulin Sensitizers Consumed in Drugstore
Figure 17. Global Insulin Sensitizers Market: Drugstore (2017-2022) & (K Units)
Figure 18. Global Insulin Sensitizers Sales Market Share by Sales Channels (2017-2022)
Figure 19. Global Insulin Sensitizers Revenue Market Share by Sales Channels in 2021
Figure 20. Insulin Sensitizers Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Insulin Sensitizers Revenue Market Share by Company in 2021
Figure 22. Global Insulin Sensitizers Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Insulin Sensitizers Revenue Market Share by Geographic Region in 2021
Figure 24. Global Insulin Sensitizers Sales Market Share by Region (2017-2022)
Figure 25. Global Insulin Sensitizers Revenue Market Share by Country/Region in 2021
Figure 26. Americas Insulin Sensitizers Sales 2017-2022 (K Units)
Figure 27. Americas Insulin Sensitizers Revenue 2017-2022 ($ Millions)
Figure 28. APAC Insulin Sensitizers Sales 2017-2022 (K Units)
Figure 29. APAC Insulin Sensitizers Revenue 2017-2022 ($ Millions)
Figure 30. Europe Insulin Sensitizers Sales 2017-2022 (K Units)
Figure 31. Europe Insulin Sensitizers Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Insulin Sensitizers Sales 2017-2022 (K Units)
Figure 33. Middle East & Africa Insulin Sensitizers Revenue 2017-2022 ($ Millions)
Figure 34. Americas Insulin Sensitizers Sales Market Share by Country in 2021
Figure 35. Americas Insulin Sensitizers Revenue Market Share by Country in 2021
Figure 36. United States Insulin Sensitizers Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Insulin Sensitizers Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Insulin Sensitizers Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Insulin Sensitizers Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Insulin Sensitizers Sales Market Share by Region in 2021
Figure 41. APAC Insulin Sensitizers Revenue Market Share by Regions in 2021
Figure 42. China Insulin Sensitizers Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Insulin Sensitizers Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Insulin Sensitizers Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Insulin Sensitizers Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Insulin Sensitizers Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Insulin Sensitizers Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Insulin Sensitizers Sales Market Share by Country in 2021
Figure 49. Europe Insulin Sensitizers Revenue Market Share by Country in 2021
Figure 50. Germany Insulin Sensitizers Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Insulin Sensitizers Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Insulin Sensitizers Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Insulin Sensitizers Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Insulin Sensitizers Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Insulin Sensitizers Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Insulin Sensitizers Revenue Market Share by Country in 2021
Figure 57. Egypt Insulin Sensitizers Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Insulin Sensitizers Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Insulin Sensitizers Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Insulin Sensitizers Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Insulin Sensitizers Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Insulin Sensitizers in 2021
Figure 63. Manufacturing Process Analysis of Insulin Sensitizers
Figure 64. Industry Chain Structure of Insulin Sensitizers
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets